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1. Introduction  
The pathophysiology of ischemia and reperfusion stress linked with the generation of 
reactive oxygen species (ROS), as well as the activation of antioxidant defense mechanisms 
are an integral part of non-immune factors implicated in the early and delayed graft 
function (DGF). Oxygen free radicals are central mediators of cellular injury that occurs 
upon postischaemic reperfusion. Studies on the mechanisms of reperfusion injury in the 
cold-preserved kidney transplant model have suggested an important role for free radicals 
generated at reperfusion from oxygen by activated xanthine oxidase. Generation of ROS is 
the main mechanism inducing ischemic/reperfusion damage of the organ. Oxygen burst is a 
trigger for complex biochemical reactions leading to generation of oxygenated lipids and 
changes in microcirculation with recruitment of neutrophils to the graft. Recently, radical 
generation has been measured in postischaemic tissues using electron paramagnetic 
resonance spectroscopy. Electron paramagnetic resonance techniques have demonstrated 
that presence of oxygen burst after postischaemic reperfusion of the graft (Hirayama et 
al.,2004). Moreover, it has been shown that free radical generation is correlated with the 
activity of the anti-oxidative system. Many markers have been researched to prove the 
presence of ROS in the transplanted tissue including malondialdehyde (MDA), glutathione 
(GSH), superoxide dismutase (SOD) and catalase (CAT). They are involved in protection 
against free radicals. Elucidation of inter-relations between these factors is important for our 
understanding of the phenomena and for implementation of perioperative procedures 
aimed at prolonging graft survival. Organ preservation seeks to ensure the functional 
viability of transplanted organs. Preservation during ischemia includes steps against 
acidosis, steps to maintain cell volume and for optimal utilization of anaerobic energy 
reserves. Previous studies have demonstrated that apart from ischemic damage, additional 
tissue injury evolves as a result of reperfusion and reoxygenation (Tilney et al., 2001). 
Energy-dependent processes occurring during cold ischemia of the graft require adequate 
levels of ATP and other high-energy compounds generated in the majority during oxidative 
catabolism of various substrates. Because oxygen is required for such reactions, the ability to 
maintain adequate levels of high-energy phosphates would appear to depend on oxygen 
delivery to graft cells (Chien et al., 2001a). Oxygen delivery during reperfusion is 
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insufficient to maintain an aerobic environment in graft tissue. It is plausible that such tissue 
hypoxia may be associated with alterations in concentrations of high-energy phosphates and 
their metabolites (Grinyo et al., 2001). Various molecular mechanisms of ischemic changes in 
the graft tissue have been demonstrated. The graft’s adenine nucleotide metabolism is 
directly linked to high-energy phosphate turnover and graft functioning. Some studies have 
shown that prolonged graft ischemia is accompanied by nucleotide degradation, but clinical 
data concerning nucleotide pool changes in renal and peripheral veins is lacking (Harris et 
al., 1996; Rabb et al., 1997). ATP is catabolized to adenosine and then to hypoxanthine. 
Nucleosides and oxypurines are released to plasma, but part of them are transported to 
erythrocytes where they are metabolized to other nucleosides and nucleotides. Ischemia-
reperfusion injury is a not only a major cause of acute renal damage but also affects its 
clinical expression, mentioned earlier: delayed graft function. DGF has a significant impact 
on short- and long-term graft survival (Chien et al., 2001b). DGF is defined as a requirement 
for dialysis in the first week post-transplantation and includes a spectrum of clinical 
manifestations, ranging from borderline function to a complete absence of graft function. 
According to recent studies (Azevedo et al., 2005; Carter et al., 2005; Woodle et al., 2005), the 
rate of DGF varies between 20% and 50% in patients receiving a first cadaver graft. 
Consequently, estimation of the ischemic damage is important and it is essential to define 
reliable markers in order to properly assess renal ischemic damage and predict DGF. 
Determination of such parameters should improve the early follow-up of renal 
transplantation and the management of patients who receive nephrotoxic 
immunosuppressive compounds such as cyclosporine, which may enhance acute tubular 
injury and reduce the long-term prognosis of the graft functions. The pathophysiology of 
acute ischemia and the pathophysiology of reperfusion of the kidney graft require further 
studies and more focus on clinical parameters.  
2. Objectives of ischemia-reperfusion injury analysis in the transplanted 
kidney 
The impairment of organ function derived from ischemia–reperfusion injury is still an 
important problem in solid organ transplantation. Cell alterations induced by ischemia 
prime the tissue for the subsequent damage that occurs during the reperfusion phase. 
Ischemia–reperfusion injury affects early graft function and influences the development of 
chronic graft dysfunction. 
Therefore the objective of the study was to determine: 
 The concentration profile of oxypurines and purine nucleosides in the renal vein of the 
kidney graft in humans during reperfusion as a marker of the energy status of kidney 
tissue and as a prognostic factor for graft function; 
 The activity of superoxide dismutase, catalase, and glutathione peroxidase in 
erythrocytes during reperfusion of the kidney graft in humans and their effect on graft 
function; 
 The relationship between purine concentrations in blood and the activity of anti-
oxidative enzymes in erythrocytes during reperfusion of the renal graft in humans; 
 The effect of trimetazidine on the concentration of purine nucleotides as markers of 
ischemia in rat kidney with ischemia-reperfusion injury. 
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2.1 Oxypurine and purine nucleoside concentrations in renal vein of allograft as 
potential markers of energy status of renal tissue 
Purine nucleosides and oxypurines are products of adenine nucleotides degradation. 
Reperfusion and reoxygenation are accompanied by production of reactive oxygen species 
and free radicals, which lead to damage of graft tissue. The aim of our study was to measure 
concentrations of adenine nucleotides and their metabolites in renal allograft vein as well as 
in recipient’s peripheral veins during the reperfusion period and to evaluate their usefulness 
as markers of tissue metabolism in kidney allografts.   
The study included 20 deceased donor kidney transplant recipients (11 males, 9 females, 
mean age 52 ± 8 years, cold ischemia time 19.9 ± 8.8 h, warm ischemia time 19.3 ± 5.7 min). 
The harvested grafts were perfused with EuroCollins preservation solution. All patients 
received standard immunosuppressive protocol with triple drug therapy including 
cyclosporine A, azathioprine, and steroids. The first blood sample (UV0) was taken from the 
recipient’s ulnar vein before anastomosing of the kidney allograft vessels with recipient’s 
iliac vessels. Next, samples were taken from the graft’s renal vein (RV1) and recipient’s 
ulnar (UV1) vein at 5 min of graft reperfusion. Five ml of blood was aliquoted into heparin-
containing tubes kept on ice. Reperfusion of the transplanted kidney was followed precisely 
with ThermaCAM SC500 thermovision camera (FLIR Systems), which detects infrared 
radiation and records digital images presenting surface temperature distribution of the 
object. We assumed that the process of total reperfusion was completed when thermal scans 
showed the homogeneous distribution of graft’s temperature. Samples RV1 and UV1 were 
taken from plastic microcatheters inserted into the renal allograft and ulnar veins after total 
tissue reperfusion when the temperature of the graft reached 35.0ºC. Two mL of blood was 
mixed with the same volume of 1.3 mol/L HClO4 and stored at -80ºC until assayed. The 
remaining blood was centrifuged within 15 min from collection at 4ºC for 10 min. Three 
hundred mL of plasma was supplemented with 300 mL of 1.3 mol/L perchloric acid and 
vortexed. Subsequently, plasma and blood samples were centrifuged at 20,000 x g and 4ºC 
for 5 min. Four hundred mL of the acid supernatant was removed and neutralized with 130-
160 mL of 1 mol/L potassium phosphate to pH 5-7. Centrifugation was repeated and the 
supernatant was withdrawn for chromatography. High-performance liquid 
chromatography (HPLC) was done to measure blood and plasma concentrations of 
adenosine triphosphate (ATP), adenosine monophosphate (AMP), guanosine (Guo), inosine 
(Ino), hypoxanthine (Hyp), xanthine (Xan), uric acid (UA), and uridine (Urd). Analyses were 
performed with Hewlett-Packard 1050 series chromatography system consisting of a 
quaternary gradient pump with vacuum degassing and piston desalting modules, 
Rheodyne 7125 manual injection valve with 20 uL loop, UV-VIS detector, and series 1100 
thermostatted column compartment. Separations were achieved on Hypersil BDS 125 x 3 
mm, 3-mm particle size column (Agilent Technologies). Modifications were introduced into 
the original method (Smolenski et al., 1990). The mobile phase flowed at a rate of 0.5 
mL/min and column temperature was 20.5ºC. Buffer composition remained unchanged (A: 
150 mmol/L, phosphate buffer, pH 6.0, containing 150 mmol/L potassium chloride; B: 15% 
acetonitrile in buffer A). The gradient profile was modified to the following content of buffer 
B in the mobile phase: 0% at 0.00 min, 2% at 0.05 min, 7% at 2.45 min, 50% at 5.05 min, 100% 
at 5.35 min, 100% at 7.00 min, 0% at 7.10 min. Samples of 100 mL were injected every 12 min 
into the injection valve loop. Absorbance was read at 254 nm. Concentrations were 
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expressed as mmol/liter of blood or plasma. Adenylate energy charge (AEC) was calculated 
using the following formula: AEC = (ATP + ADP/2)/(ATP + ADP + AMP).  
Hyp concentrations in whole blood were significantly increased in renal allograft vein after 
reperfusion as compared with peripheral (ulnar) vein before (1.82 times higher) as well as 
after reperfusion (1.61 times higher). Moreover, there was no statistically significant 
difference in Hyp peripheral vein concentrations before and after reperfusion. Similar 
differences were observed for Hyp concentrations in plasma. Plasma Hyp concentrations in 
renal vein after reperfusion were 155% and 162% higher than in peripheral vein before and 
after reperfusion, respectively. Xan concentrations in whole blood and plasma were 
significantly higher in renal vein in comparison with peripheral vein. Xan concentrations in 
plasma and whole blood from the renal vein were 155% and 163% higher before reperfusion 
and 162% and 129% after reperfusion, respectively. Ino concentrations in plasma and whole 
blood were significantly higher in renal allograft vein compared with peripheral vein in the 
post-reperfusion period. Moreover, peripheral vein Ino concentrations were significantly 
decreased after reperfusion. Guo concentrations in plasma and whole blood were higher in 
peripheral vein than in renal allograft vein after reperfusion. There was no significant 
difference in Guo peripheral vein concentrations before and after reperfusion. There was no 
significant difference between concentrations of uric acid and uridine in renal and 
peripheral veins before and after reperfusion. There was no significant difference in whole 
blood concentrations of ATP in renal and peripheral veins before and after reperfusion. 
AMP concentration in peripheral vein was decreased by 24% after reperfusion, which was 
associated with a slight increase in AEC. There was found many strong positive correlations 
between concentrations of purines in plasma and whole blood. Positive correlations 
between concentrations of most purines in plasma from the renal allograft vein and cold 
ischemia time, as well as warm ischemia time were showed. Correlations were most 
significant for Xan (with cold and warm ischemia time) and Ino and Guo (warm ischemia 
time only). 
Long ischemia time can alter electron transport in the respiratory chain. All complexes 
involved in the process show a reduction in their activity associated with structural damage. 
ATP hydrolysis during ischemia causes a rise in free inorganic phosphate, which increases 
membrane permeability. ATP hydrolysis and anaerobic glycolysis decrease the intracellular 
pH which is a factor that may protect cells from death during ischemia (Smoleński et al., 
1989). Extended ischemia causes progressive reduction of the iron-sulfur proteins associated 
with NADH dehydrogenase. During renal ischemia, ATP is degraded via ADP, AMP, 
adenosine and inosine to hypoxanthine, which is next oxidized to xanthine and uric acid. 
Catabolism of adenine nucleotides results in accumulation of hypoxanthine in ischemic 
cells. Ischemia also promotes the proteolytic conversion of xanthine dehydrogenase to 
xanthine oxidase (Arduini et al., 1988). Xanthine acts as a substrate for xanthine oxidase and 
enhances superoxide generation (Li et al., 1995). When xanthine oxidase converts 
hypoxanthine to xanthine in the presence of molecular oxygen, superoxide radicals are 
released. Reactive oxygen species generated during ischemia-reperfusion play a major role 
in microvascular dysfunction and exert direct tissue damage, leading to lipid peroxidation, 
denaturation of proteins, and oxidation of DNA (Dowell et al., 1993). During ischemia, 
elevated concentrations of inosine, hypoxanthine and xanthine may occur due to the 
breakdown of ATP (Kurokawa et al., 1996). Administration of cyclosporine, which inhibits 
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adenosine uptake by erythrocytes but not adenosine catabolism to inosine mediated by 
adenosine deaminase, is an additional factor for increasing concentrations of these 
nucleotides in recipient’s plasma (Guieu et al., 1998). However, we were not able to verify 
this hypothesis because all our patients were treated with cyclosporine. Previous studies on 
the effect of xanthine or xanthine oxidase as inducers of renal injury have produced 
inconsistent results. It was found that infusion of xanthine into isolated perfused kidneys 
increases the generation of oxygen free radicals and impairs renal function (Galat et al., 
1989). Another study showed that xanthine oxidase depletion improved renal function after 
reperfusion (Linas et al., 1990). However, some authors have revealed a lack of effect of 
inhibitors of xanthine oxidase or of xanthine itself (Zager & Gmur, 1989). Purine metabolism 
during kidney transplantation in humans were assessed (Vigues et al., 1993). ATP levels in 
renal bioptates were decreased, whereas degradation products (IMP, inosine, adenosine, 
hypoxanthine) increased during cold storage. Moreover, adenylate energy charge was 
reduced by half. Kidneys with subsequent acute tubular necrosis (ATN) had significantly 
lower levels of the total pool of adenine nucleotides at reperfusion, but there was no 
correlation between incidence of ATN and concentrations of ATP and other metabolites in 
the kidneys before and during cold preservation. Lipid peroxidation during ischemia-
reperfusion of rat kidney (Akcetin et al., 1999, 2000) was observed with decreased ATP 
levels and consecutive accumulation of hypoxanthine at the end of the ischemic period as 
well as a subsequent decline of hypoxanthine during reperfusion. In our study we measured 
levels of hypoxanthine, xanthine, inosine, guanosine, uric acid, uridine, ATP, and AMP in 
renal allograft and ulnar veins during reperfusion of kidney allografts. All these purines are 
present physiologically in the blood (Chouker et al., 2005). After reperfusion, Hyp and Xan 
concentrations in whole blood and plasma increased to the greatest extent. The catabolism 
of adenine nucleotides leads to generation of Hyp, which is metabolized to Xan. Xanthine is 
metabolized to uric acid, the final product of purine degradation in humans (Colpaert & 
Lefebvre, 2000). In our study we did not observe differences in the concentrations of uric 
acid between peripheral and renal veins. This finding can be explained by high basal 
concentrations of uric acid in blood and relatively low xanthine oxidoreductase activity in 
renal grafts (Sun et al., 2004). The relatively higher Hyp concentrations (which is a substrate 
for xanthine oxidoreductase) in renal vein than Xan concentrations (product of xanthine 
oxidoreductase) seem to confirm this hypothesis. Under conditions of low xanthine 
oxidoreductase activity, hypoxanthine is phosphoribosylated by hypoxanthine-guanine 
phosphoribosyltransferase to IMP (salvage pathway). We have shown that guanosine and 
uridine are not synthesized during ischemia and reperfusion and therefore are not useful for 
monitoring of kidney graft metabolism during reperfusion. A relatively stable erythrocyte 
adenine nucleotide concentration in the pre- and post-reperfusion period suggests that the 
process does not lead to disturbances of purine metabolism in erythrocytes. We found 
increased concentrations of oxypurines and nucleosides in plasma as well as in whole blood. 
Therefore, plasma or whole blood may be used to determine the release of these metabolites 
by the graft. However, when quick centrifugation of blood after collection is not possible, 
the only way to measure purine content is precipitation of whole blood with perchloric acid, 
which can be done immediately at the collection site. In the present study we also examined 
differences in concentrations of purine metabolites in renal allograft and peripheral veins. 
Concentrations of Hyp and Xan were significantly higher in the renal vein compared with 
peripheral vein. Higher Hyp and Xan concentrations in the renal vein were associated with 
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increased ischemic duration and can represent accelerated high-energy product breakdown. 
Therefore, we suggest that the differences in Hyp and Xan concentrations between renal and 
peripheral veins reflect changes and damage to renal tissue during reperfusion and might be 
useful for monitoring graft function during reperfusion. 
2.2 Oxypurine and nucleoside concentrations in renal veins during reperfusion as 
predictors of early graft function 
Perfusion is a process which creates the possibility of graft injury. A high perfusion pressure 
or an improper fluid composition may cause diffuse endothelial damage, creation of 
thrombi in small vessels and neutrophil infiltration (Gulec et al., 2006). Hypothermia 
downregulates the metabolism and prevents protease-dependent cell degranulation. 
Negative consequences of hypothermia and ischemia include cessation of ATP synthesis 
and Na-K-ATP synthase inhibition (Giligan et al., 2004). ATP is catabolized intracellularly to 
adenosine and then to hypoxanthine (Princemail et al., 1993; Hower et al., 1996). Both 
products migrate from the cell by means of a sophisticated membrane transport system. 
Under such conditions, xanthine oxidoreductase oxidizes hypoxanthine to xanthine and 
xanthine to uric acid. Hypoxanthine, xanthine and uric acid have only oxo substituents in 
their purine rings and are therefore called oxypurines. Uric acid is the final product of 
purine catabolism in humans. Superoxide radical is another product of reactions catalysed 
by xanthine oxidoreductase. It is toxic to the cell membrane, may cause structural damage to 
proteins and enzymes and finally may activate the arachidonic acid cascade, leading to 
production of inflammatory mediators (Grinyo et al., 2001; Skrzycki & Czeczot, 2004). The 
aim of this study was to examine whether purine and pyrimidine nucleoside concentrations 
as well as oxypurine concentrations in renal allograft and peripheral veins correlate with 
graft function.  
The study population comprised 25 recipients of cadaver kidney transplant. A first blood 
sample was taken from the recipient’s peripheral vein before anastomosing the kidney 
allograft vessels with the recipient’s iliac vessels. Subsequent samples were taken from the 
allograft renal vein and the recipient’s peripheral vein 5 min after beginning reperfusion. 
High-performance liquid chromatography was done to measure plasma concentrations of 
the oxypurines: hypoxanthine, xanthine and uric acid and the nucleosides: guanosine, 
inosine and uridine. Concentrations of Hyp, Xan and Ino were significantly higher in the 
renal than the peripheral vein. The differences between the Xan, Hyp, Ino and Urd plasma 
concentrations in the renal and peripheral veins before and 5 min after reperfusion 
correlated positively and significantly with serum creatinine concentrations 24 and 72 h 
after graft transplantation. Moreover, the concentrations of Hyp were significantly increased 
in renal transplant recipients with delayed graft function.  
Preservation of the harvested organ constitutes a prerequisite for organ transplantation. For 
kidney preservation, hypothermic storage remains the commonest technique in use. 
However, hypothermic organ preservation is associated with oxygen deprivation, which 
inevitably leads to some degree of ischemia-reperfusion injury upon transplantation 
(Smolenski et al., 1989). During renal storage before transplantation, hypothermic swelling 
of the medullary thick ascending tubules results in mechanical constriction of the 
peritubular capillaries and vasa recta (Corner et al., 2003). During reperfusion, a large 
amount of reactive oxygen species (superoxide anions, hydroxyl radicals and hydrogen 
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peroxides) is produced by the re-entry of oxygenated blood into the ischemic tissue. A long 
period of ischemia can alter the electron transport complexes. All of the complexes show a 
reduction in their activity associated with structural damage. ATP hydrolysis during 
ischemia causes a rise in free inorganic phosphate, which increases membrane permeability. 
ATP hydrolysis and anaerobic glycolysis decrease the intracellular pH, a factor that may 
protect cells from death during ischemia (Arduini et al., 1988). During renal ischemia ATP, 
as mentioned earlier, is degraded via adenosine diphosphate, adenosine monophosphate, 
adenosine and Ino to Hyp, which is oxidized to Xan and UA. The catabolism of adenine 
nucleotides results in an accumulation of Hyp in ischemic cells. Also, ischemia is associated 
with the proteolytic conversion of xanthine dehydrogenase to xanthine oxidase (Dowell et 
al., 1993). When xanthine oxidase converts Hyp to Xan in the presence of molecular oxygen, 
superoxide radical is generated. Reperfusion and reactive oxygen species which are 
generated during ischemia play a major role in microvascular dysfunction and cause direct 
tissue damage, leading to lipid peroxidation, denaturation of protein and oxidation of DNA 
(Chouker et al., 2005). During ischemia, elevated concentrations of Ino, Hyp and Xan may 
occur due to the breakdown of ATP (Colpaert & Lefebvre, 2000). Xan acts as a substrate for 
xanthine oxidase and enhances superoxide generation (Li et al., 1995). These two events may 
influence renal injury, but previous studies on the effect of Xan or xanthine oxidase as 
inducers of renal injury are inconsistent. It was shown in some studies (Galat et al., 1989) 
that infusion of Xan into isolated perfused kidneys increases the generation of oxygen free 
radicals and impairs renal function. It was found that xanthine oxidase depletion improved 
renal function after reperfusion (Linas et al., 1990), while other authors (Zager et al., 1989) 
revealed a lack of effect of inhibitors of xanthine oxidase. Assessement of purine metabolism 
during kidney transplantation in humans showed (Vigues et al., 1993), that ATP levels in 
renal bioptates were decreased whereas levels of the degradation products (inosine 
monophosphate, Ino, adenosine, Hyp) increased during cold storage. Moreover, the 
adenylate energy charge was reduced by half. Kidneys with acute tubular necrosis (ATN) 
had significantly lower levels of the total pool of adenine nucleotides at reperfusion, but 
there was no correlation between the incidence of ATN and concentrations of ATP and other 
metabolites in the kidneys before and during cold preservation. In another study (Lopez-
Marti et al., 2003), tissue levels of adenosine in rats decreased significantly 30 min following 
ischemia, whereas Xan/Hyp levels increased concomitantly with renal dysfunction and 
histological damage. In our study, which to our knowledge is the first to evaluate the purine 
and pyrimidine nucleoside as well as oxypurine concentrations in renal and peripheral 
veins during reperfusion of kidney allografts in humans, we examined plasma levels of 
Hyp, Xan, Ino, Guo, UA and Urd. After reperfusion we observed increased concentrations 
of all metabolites, with the greatest increase occurring in the concentrations of Hyp and Xan 
in renal allograft veins. This finding is in concordance with those of previous studies carried 
out in animal models and may result from disturbances in purine metabolism during kidney 
allograft reperfusion. The catabolism of adenine nucleotides leads to the generation of Hyp, 
which is metabolized to Xan. Xan is metabolized to UA, the final product of purine 
degradation in humans (Sun et al., 2004). A lack of significant differences in UA 
concentrations between the studied blood samples may have been due to high basal plasma 
concentrations of UA in the systemic circulation. Hyp and Xan are the factors that may be 
modified depending on the duration and severity of ischemia. The renal content of Hyp and 
Xan changes after renal ischemia as a consequence of ATP breakdown (Li et al., 1995). 
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Increased Hyp and Xan concentrations in the renal compared with the peripheral vein are 
manifestations of ATP breakdown in renal tissue, which occurs during reperfusion. 
Therefore, the differences between metabolite concentrations in the renal and peripheral 
veins may most precisely reflect the degree of metabolic changes in renal tissues during 
reperfusion. Moreover, we correlated the differences between metabolite concentrations in 
renal and peripheral veins with graft function and creatinine concentrations at follow-up. 
The Hyp concentrations correlated with creatinine concentrations during the first 3 days 
after transplantation, whereas there was no correlation with long-term graft function. The 
differences in Guo concentration correlated negatively with the recipients’ serum creatinine 
concentration 6 and 12 months after transplantation. Guo is metabolized to Xan by the 
kidney. Therefore, decreased metabolism of Guo to Xan may correlate with improved late 
graft function. Moreover, Hyp concentrations correlated with DGF in graft recipients. These 
results suggest that Hyp may be a useful predictor of early graft function. Another aim of 
the study was to determine whether disturbances of purine metabolism in the graft are 
associated with graft function. At transplantation it is not known when the graft will be fully 
functional, but a high concentration of Hyp in the graft’s renal vein may indicate an 
increased risk of DGF. We conclude that disturbances in purine metabolism may be 
involved in the pathomechanisms of DGF. 
2.3 Early phase of reperfusion of human kidney allograft and the erythrocyte anti-
oxidative system 
Although the problem of anti-oxidant defence is often brought up in the literature, authors 
are not precise in describing the activity of the enzymes during the first minutes after 
reperfusion. Previous studies on the animal model have shown increased free radicals 
generation during the first minutes of kidney allograft reperfusion with simultaneous 
activation of protecting mechanisms (Singh et al., 1993; Davies et al., 1995). The erythrocyte 
anti-oxidative system plays an important role in the protection against free radicals 
generated during the first minutes of reperfusion. The majority of reports regarding the 
erythrocyte anti-oxidative system derive from animal studies. Studies in humans are 
inconsistent. Therefore, the aim of our study was to examine the activity of the erythrocyte 
anti-oxidative system: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase 
(GPx) and glutathione (GSH) during reperfusion of the transplanted kidney.  
The study included 40 renal transplant recipients (22 men, 18 women, mean age 51 ± 7 years, 
cold ischaemia time 25 ± 5 h). The grafts were perfused with EuroCollins preservation 
solutions. All patients received standard immunosuppressive protocol with triple drug 
therapy including cyclosporine A, azathioprine and steroids. The ‘0’ blood sample was 
taken from the iliac vein before anastomosing of the kidney vessels with recipient’s iliac 
vessels. Then, the renal vein of the graft was cannulated and blood samples I, II and III were 
taken. The reperfusion of the transplanted kidney was measured precisely with 
ThermaCAM SC500 (AGEMA, Infrared System AB, Danderyd, Sweden) thermovision 
camera, which detects infrared radiation and records digital images presenting surface 
temperature distribution of tested objects. The process of total reperfusion was completed 
when the scans from thermovision camera showed the whole organ filled with recipient’s 
blood. Sample I was taken from the inserted catheter after total tissue reperfusion had been 
demonstrated on the scan monitor and after the temperature of the graft had reached 34 °C. 
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Blood samples II and III were taken 2 and 4 min after blood sample I. The erythrocytes were 
separated by centrifugation (300 g, 10 min), washed three times with buffered 0.9% NaCl 
solution (PBS: 0.01 mol phosphate buffer; 0.14 mol NaCl, pH 7.4) chilled to 4 °C and finally 
frozen at −70 °C. Before the analysis, erythrocytes were thawed and the haemolysate of 
washed red blood cells was diluted with distilled water and chilled to 4 °C. SOD, CAT, GPx 
activity and GSH concentrations were measured with Bioxytech (Oxis Research, Portland, 
OR, USA) kit using UV/ VIS Lambda 40 (Perkin Elmer, Wellesley, MA, USA) 
spectrophotometer. Friedmann ANOVA was used to assess statistical significance of 
changes of studied parameters. Spearman’s rank correlation coefficient was used to measure 
correlations between measured parameters. There were no statistically significant 
differences in the activity of superoxide dismutase, catalase, glutathione peroxidase as well 
as glutathione concentrations during the first 4 min after total graft reperfusion and after 
having reached the temperature of 34.0 °C by the graft. Nevertheless, there was a positive 
correlation between the activity of superoxide dismutase and glutathione peroxidase (P < 
0.005). The activity of glutathione peroxidase correlated positively with the concentration of 
glutathione in the fourth minute after total reperfusion (P < 0.005). Moreover, there was 
negative correlation between superoxide dismutase activity and glutathione concentration. 
This correlation was statistically significant before and 2 min after reperfusion (P < 0.05). 
Oxidative reperfusion injury is thought to be a central mechanism of cellular damage 
affecting all organs and tissues after ischaemia. The mechanisms of this damage, however, 
are still not fully understood. Ischaemia results in the impairment of mitochondrial anti-
oxidant defences and thereby renders cells more susceptible to oxidative stress (Arduini et 
al., 1988). The activity of anti-oxidative enzymes seems to be relatively stable during 
ischaemia (Kurokawa et al., 1996). However, glutathione peroxidase levels may decrease 
during both warm ischaemia and cold storage (Jassem et al., 1996). It has been demonstrated 
in isolated perfused kidney that oxygen free radicals are generated on postischaemic 
reperfusion (Paller et al., 1984). Several sources may be responsible for oxygen free radical 
production during ischaemia-reperfusion. These include alterations in mitochondrial 
electron transport, arachidonic acid metabolism, activation of xanthine oxidase, 
catecholamines or haemoglobin oxidation, as well as massive release of iron (Jassem et al., 
2002). The results from previous studies indicate that leucocytes play a key role in 
ischaemia-reperfusion injury (Harris et al., 1996). The phenomenon also involves 
components of a typical inflammatory reaction. Oxygen free radicals can directly trigger the 
activation of leucocytes and adhesion molecules. Leucocyte activation is significantly 
enhanced within minutes after the onset of reperfusion and remains elevated for hours 
(Rabb et al., 1997). The measurement of the activity of enzymes involved in the anti-
oxidative system is considered to be one of the reliable and sensitive assays of ischaemia-
reperfusion period. Nevertheless, only a few studies have been conducted in humans to 
investigate the activity of the anti-oxidative system in erythrocytes during ischaemia and 
reperfusion. In the present study changes in activities of superoxide dismutase, catalase, 
glutathione peroxidase and glutathione concentrations in erythrocytes during the first 4 min 
after total kidney graft reperfusion were examined. The authors did not find statistically 
significant changes in the activities of enzymes involved in the anti-oxidative system. 
However, there was significant positive correlation between the activities of superoxide 
dismutase and glutathione peroxidase. This correlation may indicate the presence of 
mechanisms coordinating the activity of these enzymes. This mechanism might be of clinical 
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importance increasing the effectiveness of superoxide radical inactivation, because H2O2, 
which is the product of superoxide dismutase, is at the same time the substrate for 
glutathione peroxidase. Moreover, there was no significant association between the 
erythrocyte anti-oxidative system and transplant outcome such as delayed graft function 
and acute rejection. In the present we analysed the enzymatic anti-oxidative system in the 
renal vein only and have not detected any changes in their activity in first 4 min of graft 
reperfusion. We have not analysed the enzymatic and non-enzymatic anti-oxidative systems 
in serum, as well as markers of biological membranes oxidative damage such as lipid 
peroxidation products. The lack of unfavourable changes during the early period of 
reperfusion such as decreased glutathione concentration, decreased glutathione peroxidase 
or SOD activity may indicate the very high capacity of anti-oxidative systems. It is possible 
that besides the erythrocyte anti-oxidative system other anti-oxidative systems such as 
plasmatic (Muzakova et al., 2000; Pechan et al., 2003;) or tissue antioxidative system 
(Dobashi et al., 2000) are involved in the defence against free radicals during allograft 
reperfusion. Nevertheless, a better understanding of changes in the anti-oxidative systems 
protecting against free radicals generation during allograft reperfusion requires further 
investigations. 
2.4 Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in 
erythrocytes in kidney allografts during reperfusion and delayed graft function 
Many markers have been researched to prove the presence of ROS in the transplanted 
tissue. Some of them, like superoxide dismutase, catalase, and glutathione peroxidase are 
considered to play a major role in graft protection against oxygen stress during reperfusion. 
The SODs appear to be the most important enzymes involved in the defense system against 
ROS, particularly against superoxide anion radicals. Three distinct isoforms of SOD have 
been identified in mammals and their genomic structure, c-DNA, and protein structure have 
been described (Skrzycki & Czeczot, 2004). Two isoforms of SOD have Cu and Zn in their 
catalytic center and are localized in either intracellular cytoplasmatic compartments (CuZn-
SOD or SOD1) or in extracellular elements (EC-SOD or SOD3). SOD1 is a homodimer with a 
molecular mass of about 32 kDa (Fattman et al., 2003; Zelko et al., 2002). It has been found in 
the cytoplasm, nuclear compartments and lysosomes of mammalian cells. SOD3 is a 
homotetramer of 135 kDa with a high affinity to heparin (Lookene et al, 2000; Oury et al., 
1996). Manganese (Mn) is the cofactor of the third SOD isoform (Mn-SOD or SOD2) which is 
localized in aerobic cells’ mitochondria (Petersen et al., 2003; Tibell et al., 1997). Early 
reperfusion is definitely associated with upregulating of SODs activity, but is also a factor 
that may lead to their rapid depletion (Davies et al., 1995; Singh et al., 1993) as huge 
amounts of ROS are released during that process. The aim of the study was to examine the 
activity of erythrocyte antioxidative system (SOD1, GPx, and CAT activity as well as GSH 
concentration) among patients with or without DGF. 
Forty patients undergoing kidney transplantation at our center were assigned to two 
groups: with or without delayed graft function. Before anastomosing kidney vessels with 
recipient’s iliac vessels, the ‘0’ blood sample was taken from the iliac vein. Next blood 
samples I, II and III were taken from the graft’s renal vein. The reperfusion of the 
transplanted kidney was evaluated precisely with the thermovision camera. Erythrocyte 
SOD1, CAT and GPx activity was measured with a spectrophotometric method. We did not 
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observe statistically significant changes in SOD1, CAT and GPx activity in erythrocytes 
during the early phase of reperfusion in patients with and without DGF. 
In humans, only a few studies have been conducted to investigate the activity of 
antioxidative system in erythrocytes during ischemia reperfusion. The excess of ROS, 
particularly of superoxide anion radicals is the main factor, which activates SODs. These 
enzymes are essential for cell protection against oxygen toxicity. As a result of the reaction 
catalyzed by SODs, hydrogen superoxide is generated and becomes a substrate for further  
reactions involving GPx and CAT. In our study the activity of erythrocyte antioxidative 
system, after total graft reperfusion in patients with and without DGF was assessed. SOD, 
CAT and GPx are the most important enzymes involved in antioxidative system during 
reperfusion. The SOD1 gene has been mapped to chromosome 21 (region 21q22) in humans 
(Levanon et al., 1985). Despite the fact that SOD1 is considered to be constitutively 
expressed, transcriptional regulation of SOD1 is highly controlled depending on extra- and 
intracellular conditions (Crapo et al., 1992). SOD1 mRNA level elevates in response to a 
wide array of mechanical, chemical and biological messengers such as heat shock, shear 
stress or hydrogen peroxide (Dimmerel et al., 1999; Hass & Massaro, 1988; Inoue et al., 1996; 
Yoo et al., 1988). SOD1 was fund to have a widespread distribution in a variety of tissues 
(Crapo et al., 1992). Early reperfusion is definitely associated with upregulating of SODs 
activity, but is also a factor that may lead to their rapid depletion (Davies et al., 1995; Singh 
et al., 1993) as huge amounts of ROS are released during that process. It was shown that 
MDA concentration as a marker of lipid peroxidation in the renal vein after 2 min of 
reperfusion increased by 30% compared with the systemic baseline value (Hower et al., 
1996). In rats, the endogenous scavenger SOD, especially the cytoplasm copper-zinc (CuZn) 
form, is rapidly depleted during ischemia and reperfusion (Davies et al., 1995; Singh et al., 
1993). Numerous studies have assessed the potential benefits of exogenous SOD 
administration in preventing reperfusion injury, but conclusions are ambiguous. In one 
study (Land et al., 1994) intraoperative human recombinant CuZn-SOD administration led 
to a significant reduction of early and late immunological complications. The effect, 
according to the authors, could be related to the enzyme’s antioxidant action on ischemia-
reperfusion injury of the renal allograft, which is a potential factor that reduces the 
immunogenicity of the graft. In another experimental study protective effect of exogenous 
Cu/Zn SOD proved to be minimal, probably because of very short half-period of SOD 
counted in minutes (Bayati et al., 1988; Johnson & Weinberg, 1993). In those studies, 
however, the authors did not specify which form of Cu/ Zn SOD was administered. An 
experimental study observed (Yin et al., 2001), that increased levels of intracellular SOD in 
kidney induced by its transfection with an adenoviral vector minimized ischemia-
reperfusion induced tubular injury and improved post-ischemic renal function. Results of 
the studies suggest that some changes in SOD activity occur in graft’s vein during the first 
few minutes after reperfusion. In our experiment no significant changes in graft’s vein SOD1 
activity were observed either in the group of patients with DGF or in the group without 
DGF, as the enzyme activity in sample III was comparable with its activity in sample 0. 
Early period of reperfusion from clamp removal till the whole graft is filled with recipient’s 
blood and reaches the temperature of 36.6ºC is essential for further graft function. Therefore 
appropriate assessment of the process is very important. The use of thermovision camera 
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was the important point of our research. In most cases the assessment of graft reperfusion is 
performed by the surgeon without any objective method during the operation. However, 
proper evaluation of the process seems to be crucial in everyday practice as well as in 
experimental studies. Thermovision camera helped us to determine the moment when the 
whole graft was perfused with recipient’s blood (Gnaiger et al., 1999; Jassem et al., 2002;  
Ostrowski et al., 2004). We suggest that this method is an important step to objective 
assessment of early reperfusion. In our study the erythrocyte antioxidative system remained 
stable after total reperfusion. The activity of SOD, CAT, GPx as well as GSH concentrations 
did not change statistically significantly during the reperfusion. Taking into consideration 
the results of our and previous studies which proved the beneficial effect of Cu/Zn SOD on 
the graft in the early stages after transplantation, we suggest that extracellular antioxidative 
system proves to be essential for protection against ROS during early stages after 
reperfusion. Extracellular matrix and the cell surface is the main EC SOD (SOD3) 
localization (Marklund, 1984, 1994) and structural differences between SOD1 and SOD3 
seem to be the main factor that influences their activity and the place of action. In 
experiments with fluorescently labeled SOD (Emerit et al., 2002) clearly, it was showed that 
the enzyme binds to cellular membranes and the intensity of binding varies according to cell 
type. The differences observed for binding were concomitant with decreased inhibition of 
stimulated superoxide production. Taking into account the results of present study we 
suggest that the erythrocyte antioxidative system during the reperfusion is stable, and the 
main protective role against free radicals plays the extracellular antioxidative system, 
nevertheless this hypothesis requires further investigations. 
2.5 Hypoxanthine as a graft ischemia marker and catalase activity during reperfusion  
It has been proposed that xanthine oxidase may be a central mechanism of postischemic free 
radical generation in a variety of cells. Superoxide dismutase, catalase, glutathione and 
glutathione peroxidase are involved in protection against free radicals (Colpaert &Lefebrve, 
2000; Komada et al., 1999; Radi et al., 1997).  The aim of the study was to examine the 
correlation between the concentrations of ischemia markers: hypoxanthine or inosine and 
the activity of erythrocyte SOD, CAT as well as GPx.  
The study included 40 renal transplant recipients. Before anastomosis of the kidney vessels 
with the recipient’s iliac vessels, a “0” blood sample was taken from the iliac vein. Then, 
after anastomosis, the renal vein of the graft was cannulated and blood samples I, II, and III 
were obtained. The reperfusion of the transplanted kidney was measured with a 
thermovision camera ThermaCAM SC500. The study included 40 renal transplant recipients 
(21 men, 19 women), of mean age 52 ± 8 years with mean cold ischemia time of 26 ± 3 hours. 
The grafts were perfused with EuroCollins preservation solution. All patients received 
cyclosporine, azathioprine, and steroids. The “0” blood sample was taken from the iliac vein 
before anastomosing the kidney vessels with recipient iliac vessels. Then, the graft renal 
vein was cannulated to obtain blood samples I, II, and III. The reperfusion of the 
transplanted kidney was measured with thermovision camera (ThermaCAM SC500), which 
detects infrared radiation, recording digital image presenting the surface temperature 
distribution of the organ. The process of total reperfusion was completed when the scans 
from thermovision camera showed the whole organ filled with recipient blood. The sample I 
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was taken from the inserted catheter after total tissue reperfusion had been shown by the 
scan monitor and after the temperature of the graft had reached 34°C. Blood samples II and 
III were taken 2 and 4 minutes after blood sample I, respectively. Blood was aliquoted into 
heparin containing tubes kept in ice. One tube was centrifuged within 15 minutes from 
collection. Plasma (300 µL) was supplemented with 300 µL of 1.3 mol/L perchloric acid, 
vortexed, and centrifuged (5 min/20000 g/4°C). The acid supernatant (400 µL) was removed 
and neutralized with 130 to 160 µL of 1 mol/L potassium phosphate to pH 5 to 7.7 
Centrifugation was repeated and the supernatant withdrawn for high-performance liquid 
chromatography (HPLC) to measure plasma concentrations of Hyp and Ino. Analyses were 
performed with a Hewlett-Packard (now Agilent) Series 1050 chromatography System. 
SOD, CAT, and GPx activities were measured with spectrophotometric methods using an 
UV/VIS Lambda 40 (Perkin Elmer) spectrophotometer. We used Bioxytech (Oxis Research, 
USA) kits. The results are presented per gram of hemoglobin, measured using Drabkin’s 
method. Friedmann ANOVA was used to assess the significance of changes in the studied 
parameters. Spearman’s rank correlation coefficient was used to measure correlations 
between analysed parameters. 
The plasma concentrations of Hyp and Ino increased in statistically significant fashion 
immediately after total tissue reperfusion (P < .0001) then gradually decreasing. There were 
no statistically significant differences in the activities of CAT, SOD, and GPx. The activity of 
catalase at 4 minutes after total tissue reperfusion (sample III) correlated positively with 
hypoxanthine concentrations immediately after total tissue reperfusion (sample I; Rs = 
+0.49), 2 minutes after total tissue reperfusion (sample II; Rs = +0.47), and 4 minutes after 
total tissue reperfusion (sample III; Rs = +0.46). There were no statistically significant 
correlations between CAT activity and Hyp concentrations in the iliac vein before 
transplantation. Similar correlations were observed between CAT activity and Ino 
concentrations; those values, however, did not reach statistical significance (P < .07). 
Moreover, there were no statistically significant correlations between Hyp and Ino 
concentrations and SOD and GPx activities. 
For kidney preservation, hypothermic storage remains the most common technique. 
However, hypothermic organ preservation is associated with oxygen deprivation, which 
inevitably leads to some degree of ischemia-reperfusion injury upon transplantation (Hower 
et al., 1996). During reperfusion, a large amount of reactive oxygen species (superoxide 
anions, hydroxyl radicals, and hydrogen peroxides) are produced by the reentry of 
oxygenated blood into the ischemic tissue (Grinyo, 2001). The catabolism of adenine 
nucleotides results in an accumulation of Hyp in ischemic cells. Ischemia is also associated 
with the proteolytic conversion of xanthine dehydrogenase to xanthine oxidase (Sermet et 
al. 2000). When xanthine oxidase converts Hyp to xanthine in the presence of molecular 
oxygen, superoxide radical is generated. SOD, CAT, GSH, and GPx are involved in defense 
against these processes (Dowell et al., 1993). In the present study we evaluated the 
correlation between the concentration of ischemia markers (Hyp or Ino) and the activity of 
erythrocyte SOD, CAT, as well as GPx. Immediately after total reperfusion we observed a 
statistically significant increase in Hyp and Ino plasma concentrations, changes which 
retreated after reperfusion. Elevated concentrations of Hyp and Ino during ischemia may 
occur due to ATP breakdown. The elevated concentrations of Hyp and Ino correlated with 
increased activity of catalase in erythrocytes. We did not, however, observe a correlation 
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with SOD activity. Characterization of the human SOD gene has revealed several potential 
transcriptional regulatory sites, none of which have been demonstrated to be active in the 
human SOD gene (Foltz & Carpo, 1994). The presence of those possible regulatory 
sequences suggests that SOD expression may be regulated by multiple stimuli. Recently 
SOD expression has been shown to be regulated by several cytokines. Interferon-Ǆ results in 
an increased expression of SOD, whereas tumor necrosis factor-ǂ and transforming growth 
factor- ǃ decrease enzyme expression (Marklund 1992). Various forms of direct oxidative 
stress do not, however, seem to affect SOD expression (Stralin & Marklund, 1994). The 
results of the present study suggested that CAT activity may correlate with the 
concentration of Hyp and other mediators of oxidative stress in the graft renal vein. We 
hypothesize that catalase activity is regulated by factors that protect against a burst of free 
radicals upon postischemic reperfusion. The hypothesis requires further investigation. 
2.6 Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia–
reperfusion injury 
Total adenine nucleotide concentration (TAN) is a measure of pool of all (high- and low-
energy) nucleotides containing adenine moiety (ATP + ADP + AMP). The balance between 
these three nucleotides is maintained by the action of adenylate kinase which catalyzes the 
reversible transphosphorylation of two molecules of ADP to one ATP and one AMP (Saiki et 
al., 1997). Adenylate energy charge is a measure of the balance between adenine nucleotides. 
Its value (Atkinson & Walton, 1967) is between 0 (when only low-energy AMP is present in 
the cell) and 1 (when only high-energy ATP is present). Dephosphorylation of AMP to 
adenosine catalyzed by 5’-nucleotidases is responsible for loss of AMP and decrease in TAN 
concentration (Welsh & Lindinger, 1997). Preservation of TAN pool is crucial to 
maintenance of normal purine metabolism in the cell since the replenishment of the lost 
adenine nucleotide molecules (via synthesis “de novo” or salvage reactions) would require 
additional energy, which is lacking during ischemia. Therefore considerable loss of adenine 
nucleotides during ischemia results in vicious circle leading to irreversible deficit of energy 
which cannot be recovered during reperfusion (Hiraoka et al.,1993). The catabolism of 
adenine nucleotides results in an accumulation of hypoxanthine in ischemic cells. Ischemia 
is also associated with proteolytic conversion of xanthine/hypoxanthine dehydrogenase to 
xanthine/hypoxanthine oxidase (Colpaert & Lefebvre, 2000; Komada et al., 1999; Sun et al., 
2004). With the supply of molecular oxygen upon reperfusion of ischemic tissues, xanthine 
oxidase metabolizes xanthine and hypoxanthine to uric acid and free radicals are generated. 
The generation of oxygen free radicals during reperfusion may overcome the capacity of 
physiologic scavengers. The excess of these highly reactive species results in cytotoxicity 
and induces peroxidation of the lipid cell membrane (Akcetin et al., 2000; Pincemail et al., 
1993). It has been shown that the free radicals generation correlates with the activity of 
antioxidative system (Singh et al., 1993). The excess of ROS, particularly of superoxide anion 
radicals is the main factor which activates superoxide dismutases. These enzymes are 
essential for cell protection against oxygen toxicity. As a result of the reaction catalyzed by 
SODs, hydrogen superoxide is generated and becomes a substrate for further reactions 
involving glutathione peroxidase and catalase (Gulati et al., 1993; Yoo et al., 1999). In 
experimental systems of ischemia–reperfusion injury, it has been shown that mitochondria 
may play a key role in oxidative injury (Vlessis & Mela-Riker, 1989). Mitochondria are the 
powerhouse of the cell and provide ATP through the oxidative phosphorylation process. 
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Moreover, mitochondria were identified as an important source of hydrogen peroxide 
(Jassem et al., 2002). Ischemia causes also extensive cytoskeletal and mitochondrial damage 
and uncoupling of oxidative phosphorylation (Akcetin et al., 1999; Caraceni et al., 2005). The 
effect of trimetazidine on the mitochondrial function of ischemic Wistar rat was studied 
(Monteiro et al., 2004). In this model, trimetazidine had a preferential action on the oxidative 
system, increasing its enzyme activity and decreasing O2 consumption after 
phosphorylation; this could decrease oxygen free radical production and increase 
mitochondrial integrity, thus allowing the maintenance of the electrical potential. 
Trimetazidine (TMZ) is an anti-ischemic agent. Its anti-ischemic effects have been 
experimentally assessed in various models including cell cultures, isolated and perfused 
organs, and also in vivo (Baumert et al., 1999; Hauet et al., 2000). TMZ mostly acts on 
mitochondria by restoring ATP synthesis, which was blocked by the Ca overload, by 
releasing Ca accumulation in the matrix, and by restoring the mitochondrial membrane 
impermeability and its affinity for protons. Moreover, TMZ inhibits the excessive release of 
oxygen free radicals, increases glucose metabolism, limits intracellular acidosis, protects 
ATP stores, reduces membrane lipid peroxydation and inhibits neutrophils infiltration after 
ischemia and reperfusion (Catroux et al., 1990; Hauet et al., 1998a). The aim of the study was 
to examine the effect of TMZ on nucleotide profile in rat kidney with ischemia–reperfusion 
injury.  
Male Wistar rats weighing 300–350 g were used in this experiment. They were allowed to 
acclimatize for a minimum of 10 days prior to the study. The rats were housed in the room 
maintained at 21 ± 1 ºC with 12 h light–dark cycle with the light cycle beginning at 6:00 a.m. 
All animals were fed standard rat chow and water ad libitum. Food was withheld overnight 
before surgery. Animals were divided into two groups: animals treated with TMZ (n = 14) 
and control group receiving placebo (n = 13). The aqueous solution of trimetazidine 10 
mg/kg/day was administrated by gavages vehicle twice a day at 8.00 a.m. and 18.00 p.m. 
for 30 days. In this study, the effect of trimetazidine on adenine nucleotide profile was 
examined after ischemia-reperfusion as well as by normal renal blood flow. Therefore the 
left kidney artery was clamped to induce the ischemia-reperfusion injury, whereas the blood 
flow in right kidney artery remained unchanged. The rats were anesthetized with ketamine 
(Ketolar). The abdominal cavity was opened via middle incision. The aorta, vena cava 
inferior, and finally left and right renal vessels were atraumatically isolated. An atraumatic 
microvascular clamp was placed on the left renal artery for 15 min to induce the ischemia of 
renal tissue. The catheter (Becton Dickinson Vascular Access Inc., Sandy, Utah, USA) was 
inserted in aorta. After clamp removal from the left renal artery, the aorta and vena cava 
superior were clamped over the right and left renal artery, and then vena cava inferior was 
catheterized to enable the outflow of perfusion solution. The EuroCollins solution was 
perfused continuously at 100 ml/h during 12 min (temperature of the solution, +4 ◦C; 
volume of injected solution, 20 ml). Finally, bilateral nephrectomy was performed. After 
obtaining tissue samples from both kidneys for histological analysis the right and left 
kidneys were immediately frozen in liquid nitrogen within a few seconds from collection 
and transferred to 1.5 mL airtight tubes immersed in liquid nitrogen. Subsequently, they 
were minced with a metal homogenizer pre-cooled in liquid nitrogen, transferred to capped 
1.5 mL tubes containing 500 µL of 0.4 mol/L cold perchloric acid, and homogenized for 15 s 
with a knife microhomogenizer (Dispergierstation T8.10, IKA). Centrifugation followed at  
4 ◦C (16,000 × g, 5 min), 400 µL of the supernatant was transferred to a test tube and 
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neutralized with 115 µL of 1 mol/L potassium phosphate. Centrifugation was repeated and 
the supernatant was taken for high performance liquid chromatography. HPLC was done to 
measure tissue and whole blood concentrations of the following 17 nucleotides, nucleosides, 
and oxypurines: adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine 
monophosphate (AMP), adenosine (Ado), guanosine triphosphate (GTP), guanosine 
diphosphate (GDP), guanosine monophosphate (GMP), guanosine (Guo), inosine 
monophosphate (IMP), inosine (Ino), hypoxanthine (Hyp), xanthine (Xan), uric acid (UA), 
uridine (Urd), nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine 
dinucleotide phosphate (NADP). Analyses were performed with Hewlett–Packard Series 
1050 chromatography system consisting of a quaternary gradient pump with vacuum 
degassing and piston desalting modules, Rheodyne 7125 manual injection valve with 20 µL 
loop, UV–vis detector, and series 1100 thermostatted column compartment. Separations 
were achieved on Hypersil BDS 125 mm × 3 mm, 3 µm particle size column (Agilent). The 
mobile phase flowed at a rate of 0.5 mL/min and column temperature was 20.5 ºC. Buffer 
composition remained unchanged (A: 150 mmol/L phosphate buffer, pH 6.0, containing 150 
mmol/L potassium chloride; B: 15% acetonitrile in buffer A). The gradient profile was 
modified to the following content of buffer B in the mobile phase: 0% at 0.00 min, 2% at 0.05 
min, 7% at 2.45 min, 50% at 5.05 min, 100% at 5.35 min, 100% at 7.00 min, 0% at 7.10 min. 
Samples of 100 µL were injected every 12 min into the injection valve loop. Absorbance was 
read at 254 nm. Concentrations were expressed as median in nmol/mg protein. For 
histology, kidneys were fixed in buffered formalin and 2 µm paraffin-embedded sections 
were stained using hematoxylin–eosin and periodic acid-Schiff (PAS). Twenty randomly 
selected areas in a renal cortex were examined under light microscopy at 400×. Severity of 
acute tubular damage was semi-quantitatively scored by estimating the percentage of 
tubules that showed epithelial necrosis or had necrotic debris as follows: 0, none; 1+ (mild), 
<10%;  2+ (moderate), 10–50%; 3+ (severe), >50%. Mann–Whitney test was performed to 
compare each parameter between two groups. The significance of the differences between 
the parameters in the left (clamped, with ischemia) and the right (non-clamped, without 
ischemia) kidney was assessed using Wilcoxon test. Severity of acute tubular damage was 
compared between groups with x2-test. 
Tissue concentrations of ATP, ADP, AMP, TAN and AEC were significantly increased in 
kidneys from rats treated with TMZ in comparison with rats receiving placebo. 
Concentrations of products of nucleotide degradation: inosine, guanosine and uridine, as 
well as oxypurines: Hyp and Xan, were significantly decreased in rats treated with 
trimetazidine. Moreover, significantly less pronounced acute tubular necrosis was observed 
in kidneys of rats treated with TMZ. Tissue concentrations of ATP, ADP, AMP, TAN and 
AEC values were significantly increased in kidneys with or without ischemia in rats treated 
with trimetazidine in comparison with rats receiving placebo. Moreover, the concentrations 
of GTP and GDP were increased, although the concentrations of GMP were decreased in 
kidney from rats treated with trimetazidine. The concentrations of products of nucleotide 
degradation: Ino, Guo and Urd, as well as oxypurines: Hyp and Xan, were significantly 
decreased in rats treated with trimetazidine. These results suggest the protecting activity of 
trimetazidine against the dephosphorylation of nucleotides. Nevertheless, the concentration 
of Ado was significantly increased in rats treated with trimetazidine. The increased Ado 
concentrations may be the result of increased adenine nucleotide synthesis or inhibition of 
adenosine to inosine degradation. The increased tissue adenosine concentrations may be the 
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important kidney preconditioning factor improving the tissue metabolism during ischemia. 
Concentrations of NAD were significantly increased in kidneys from rats treated with 
trimetazidine. It might be associated with enhanced ATP availability, essential for NAD 
synthesis. NADP concentrations were decreased in rats treated with trimetazidine. 
Decreased NADP concentrations may suggest the increase in NADPH/NADP ratio. 
NADPH is involved in the antioxidative system; therefore the increased NADPH 
concentration may have beneficial effects in ischemic tissues. Analyzing tissue 
concentrations of ATP, ADP, AMP, GDP, GMP and TAN between kidneys with and without 
ischemia we observed the decrease of these nucleotide concentrations associated with 
ischemia in rats treated with TMZ, although the concentrations in rats receiving TMZ 
remained significantly higher as compared to values in rats from control group. There were 
no statistically significant differences in NAD concentration between kidney with and 
without ischemia, the NADP concentrations were significantly decreased in kidney with 
ischemia in rats treated with trimetazidine as well as placebo. Tissue concentrations of Guo 
were significantly decreased in kidneys after ischemia in rats treated with trimetazidine. It 
may be the result of decreased guanylate degradation in kidneys treated with trimetazidine 
during ischemia. Hyp concentrations were significantly decreased in kidneys after ischemia 
in rats treated with trimetazidine, but in rats receiving placebo these values were increased. 
Decreased tissue concentrations of Hyp may be associated with diminished degradation of 
adenine nucleotides during ischemia in rats treated with trimetazidine. The histological 
changes of ischemic acute tubular necrosis depends on the intensity of ischemic trigger and 
varies with the evolution of the lesion in relationship to the onset of initial injury. Among 
many histologic features of ATN individual, cell necrosis with denudation of the basement 
membrane, shedding of epithelial cells and necrotic debris into the lumen are most 
characteristic whereas glomerular morphology typically remains unchanged. The 
commonest finding in kidneys from control group was moderate ATN followed by 
complete necrosis of epithelial tubular cells and denudation of basement membranes seen in 
many tubules. Mild ATN characterized by the presence of fragments of cells within the 
tubular lamina of single tubules was significantly more frequent in kidneys from rats treated 
with trimetazidine than in control groups (p < 0.001 and <0.05, respectively). Severe ATN in 
kidneys from the trimetazidine treated rats was not detected. The intensity of ATN did not 
differ significantly between kidneys with and without ischemia. The significantly less 
pronounced ATN observed in kidneys of rats treated with TMZ suggests that TMZ protects 
the tubules from ischemic damage. 
Ischemia–reperfusion injury affects early graft function and influences the development of 
chronic graft dysfunction. Ischemia favors the depletion of cellular adenosine nucleotides, 
alterations in membrane ATP-dependent ionic transporters, and the intracellular 
accumulation of Ca, Na and water. The great swelling of endothelial and tubular epithelial 
cells due to ischemia not only increases the acidosis caused by anaerobic metabolism, but 
also alters cell permeability and favors the obstruction of capillary flow (Facundo et al., 
2005). The reperfusion of ischemic tissues also increases the release of intracellular enzymes. 
In anaerobic metabolism the energy production for essential processes is greatly reduced. 
Failure of ion pumping with rapid loss of electrochemical gradients results in translocation 
of ions. The production of oxygen-derived free radicals is considerably increased during 
tissue ischemia caused by dissociation of oxidative phosphorylation, which results in 
univalent reduction of oxygen, catabolism of ATP into hypoxanthine and uric acid (Elsner et 
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al., 1998). In particular, the reduced form of NADH, the essential coenzyme for all the 
oxidative enzymatic reactions, accumulates and is only utilized in reactions such as lactate 
formation from pyruvate, which under ischemia cannot be used in Krebs cycle. A general 
assumption is that NADP – the cofactor of anabolic enzymatic reactions – accumulates in the 
reduced form (NADPH), following the same pattern of the NADH/NAD redox couple. 
Under conditions of impaired NADPH production, the possible utilization of cofactor can 
remain unbalanced. There is clear evidence that a highly-reduced state of NADP and of 
glutathione redox couples exerts a major protective function (Hai et al., 2005). In particular 
glutathione is involved in the protection against free radical induced damage through 
glutathione peroxidase. Interruption of blood supply and lack of oxygen during ischemia 
lead to anaerobic metabolism that entails a depletion of ATP (Cruthirds et al., 2005). In this 
study we examined the effect of TMZ on nucleotide concentrations in renal tissue after 
ischemia–reperfusion. The animals received TMZ 4 weeks before the experiment. Tissue 
concentrations of the majority of nucleotides involved in energetic processes in cells were 
significantly increased in renal tissues from animals receiving TMZ as compared to rats 
receiving placebo. Although the concentrations of purine nucleotides decreased during 
ischemia in rats treated with TMZ, they remained still significantly increased as compared 
to control group. Our results suggest that TMZ increases the synthesis of purine and 
pyridine nucleotides leading to improvement of energy status of cells. Moreover in 
histological pictures the severe tubular necrosis in kidneys from animals treated with TMZ 
was not detected. In kidneys from animals receiving TMZ the prevalence of mild ATN was 
observed. Various experimental studies have shown that TMZ has preserved the 
intracellular concentration of ATP and inhibited the extracellular leakage of K+ during 
cellular ischemia (Hauet et al., 1998b). Additionally it prevents excessive release of free 
radicals, which are particularly toxic to phospholipid membranes and are responsible for 
both the fall in intracellular ATP concentration and the extracellular leakage of K+ (Catroux 
et al., 1990; Maupoil et al., 1990). The protective effect of TMZ on the decreased levels of 
NADPH caused by ischemia-reperfusion suggests that this agent has some beneficial effects 
against the activation of NADPH-dependent oxidases. They represent the most significant 
O2 source in tissues. TMZ is also efficient in preventing inflammatory cell infiltration 
(Baumert et al., 2004). Current immunosuppressive protocols use treatments that might 
worsen nonimmunological mechanisms such as ischemia, hypertension and direct drug 
nephrotoxicity. TMZ has been shown to restore ATP synthesis from cyclosporine-treated 
isolated mitochondria suspensions (Simon et al., 1997). Moreover, it has been shown that 
TMZ significantly reduced lipid peroxidation after 60 min warm renal ischemia followed by 
15 min reperfusion (Hauet et al., 1998c). TMZ decreased also the concentrations of 
malondialdehyde and increased the activity of glutathione peroxidase in rat’s kidney after 
warm ischemia (Ozden et al., 1998). Recipient treatment with trimetazidine improved graft 
function and protected energy status after lung transplantation (Inci et al., 2001). The effects 
of trimetazidine in a rat model of renal ischemia–reperfusion injury were investigated (Kaur 
et al., 2003). The ischemic kidneys of rats showed severe hyaline casts, epithelial swelling, 
proteinaceous debris, tubular necrosis, medullary congestion and hemorrhage. 
Trimetazidine markedly reduced elevated levels of tissue lipid peroxidation and 
significantly attenuated renal dysfunction and morphological changes in rats subjected to 
renal ischemia–reperfusion. Singh et al. studied the effect of trimetazidine on ischemia–
reperfusion induced renal failure in rats as well as the protective effect of trimetazidine 
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against the damage inflicted by reactive oxygen species. Pretreatment of animals with 
trimetazidine markedly attenuated renal dysfunction, morphological alterations and 
restored the depleted renal antioxidant enzymes (Singh & Chopra, 2004). The results of 
present study have shown that trimetazidine reduced the dephosphorylation of nucleotides 
caused by renal ischemia-reperfusion and this correlated with a reduction of histological 
evidence of renal injury. Because the rejection is initiated by the response to injury sustained 
during the transplant process and because TMZ may diminish the reperfusion injury, it 
seems that this drug could be useful in limiting the complications after cadaver organ 
transplantation and preventing the initiation of rejection. 
3. Conclusion  
1. The profile of oxypurines and purine nucleosides in the renal vein of the reperfused 
graft in humans appears to be a reliable marker of the energy status of kidney tissue 
and a prognostic factor for early graft function. 
2. Concentrations of hypoxanthine and xanthine in the renal and peripheral vein are 
useful for monitoring the energy status of the graft during reperfusion. 
3. The early phase of reperfusion in humans is without significant effect on the activity of 
superoxide dismutase, catalase, or glutathione peroxidase in erythrocytes from the graft 
vein. The activity of anti-oxidative enzymes in erythrocytes from the graft vein does not 
correlate with early graft function and as such is without value as a prognostic factor for 
graft function. 
4. Hypoxanthine appears to stimulate catalase activity which is an important element of 
the antioxidant system. 
5. Trimetazidine inhibits dephosphorylation of purine nucleotides and histological 
changes in tubules of the ischemic rat kidney, thereby limiting the extent of ischemia-
reperfusion injury. 
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